Biotech Values

[Shengli]

One other piece of pure babble on the upcoming AASLD.
If you could have polled the top Hepatology HCV researchers 12 months ago on when we would see an all oral regimen.The average time period guessed would have been 5 years away.Now we are seeing fissures in that consensus.One expert recently told me at this upcoming AASLD we may see some shocking data on an all oral regimen.He also stated that some companies are looking at unique approaches to a back door indication for a fast track approval.
Of course i am only going to speak in generalities.This years meeting will be very exciting !